← Leaderboards
Russell Paul Goodman
Massachusetts General Hospital
$2,719,051
Attributed
$2,719,051
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $668K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,719,051 · 4
By mechanism
R01$1,532,519 · 1
K08$864,500 · 1
R03$260,022 · 1
F32$62,010 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Elizabeth K Speliotes$12,106,253
- Alejandro Soto-Gutierrez$6,883,976
- Kathleen Elizabeth Corey$4,109,943
- Kathryn J Moore$30,608,901
- Raymond T Chung$38,306,004
Others in their field
Top investigators on “Metabolic”
- David M Nathan · Massachusetts Institute Of Technology$157,845,616
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$144,157,234
- Judith S. Currier · University Of California Los Angeles$141,260,706
- John M Lachin · George Washington University$139,991,329
- Randall J Bateman · Washington University$124,168,384
- Carol Nesel · Westat$116,355,411
Research focus
MetabolicHepaticOxidation-ReductionMetabolismLiverIn VivoNadhGenesInnovationCirculating BiomarkersGeneticReactionHydroxybutyratesFatty LiverMouse ModelLiver DiseasesLiver TransplantationMortalityLipidsPathogenesisExperimental StudyMorbidity - Disease RateNon-Alcoholic Fatty Liver DiseaseNovel Strategies
Grant awards (11)
An NADH-ChREBP axis in fatty liver disease and dyslipidemia$471,860
R01 · FY2025 · DK · contact PI
An NADH-ChREBP axis in fatty liver disease and dyslipidemia$522,817
R01 · FY2024 · DK · contact PI
An NADH-ChREBP axis in fatty liver disease and dyslipidemia$537,842
R01 · FY2023 · DK · contact PI
Identifying genetic regulators of hepatic reductive stress in diversity outbred mice$130,129
R03 · FY2023 · DK · contact PI
A METABOLIC BIOMARKER OF HEPATIC NADH/NAD+ RATIO$172,600
K08 · FY2022 · DK · contact PI
Identifying genetic regulators of hepatic reductive stress in diversity outbred mice$129,893
R03 · FY2022 · DK · contact PI
A METABOLIC BIOMARKER OF HEPATIC NADH/NAD+ RATIO$172,600
K08 · FY2021 · DK · contact PI
A METABOLIC BIOMARKER OF HEPATIC NADH/NAD+ RATIO$172,600
K08 · FY2020 · DK · contact PI
A METABOLIC BIOMARKER OF HEPATIC NADH/NAD+ RATIO$172,600
K08 · FY2019 · DK · contact PI
A METABOLIC BIOMARKER OF HEPATIC NADH/NAD+ RATIO$174,100
K08 · FY2018 · DK · contact PI
Compartment-Specific NAD+ Regeneration in Alcohol-Induced Liver Disease$62,010
F32 · FY2016 · DK · contact PI